Connection

Taisheng Li to China

This is a "connection" page, showing publications Taisheng Li has written about China.
Connection Strength

0.270
  1. High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China. Front Immunol. 2021; 12:627844.
    View in: PubMed
    Score: 0.033
  2. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020 Dec; 9(1):687-690.
    View in: PubMed
    Score: 0.032
  3. Prolonged presence of viral nucleic acid in clinically recovered COVID-19 patients was not associated with effective infectiousness. Emerg Microbes Infect. 2020 Dec; 9(1):2315-2321.
    View in: PubMed
    Score: 0.032
  4. Cerebral Vasoreactivity Evaluated by the Breath-Holding Challenge Correlates With Performance on a Cognitive Screening Test in Persons Living With Treated HIV Infection in China. J Acquir Immune Defic Syndr. 2018 11 01; 79(3):e101-e104.
    View in: PubMed
    Score: 0.028
  5. The clinical characteristics and the features of immunophenotype of peripheral lymphocytes of adult onset chronic active Epstein-Barr virus disease at a Tertiary Care Hospital in Beijing. Medicine (Baltimore). 2018 Mar; 97(9):e9854.
    View in: PubMed
    Score: 0.027
  6. Delays in HIV diagnosis and associated factors among patients presenting with advanced disease at a tertiary care hospital in Beijing, China. PLoS One. 2017; 12(8):e0182335.
    View in: PubMed
    Score: 0.026
  7. Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease. BMC Infect Dis. 2017 04 20; 17(1):287.
    View in: PubMed
    Score: 0.025
  8. A cohort autopsy study defines COVID-19 systemic pathogenesis. Cell Res. 2021 08; 31(8):836-846.
    View in: PubMed
    Score: 0.008
  9. Significance of serology testing to assist timely diagnosis of SARS-CoV-2 infections: implication from a family cluster. Emerg Microbes Infect. 2020 Dec; 9(1):924-927.
    View in: PubMed
    Score: 0.008
  10. Aging in COVID-19: Vulnerability, immunity and intervention. Ageing Res Rev. 2021 01; 65:101205.
    View in: PubMed
    Score: 0.008
  11. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients. J Thromb Thrombolysis. 2020 Oct; 50(3):580-586.
    View in: PubMed
    Score: 0.008
  12. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19. Clin Immunol. 2020 05; 214:108408.
    View in: PubMed
    Score: 0.008
  13. Comparison of the prevalence of respiratory viruses in patients with acute respiratory infections at different hospital settings in North China, 2012-2015. BMC Infect Dis. 2018 02 08; 18(1):72.
    View in: PubMed
    Score: 0.007
  14. Next-generation sequencing of the cerebrospinal fluid in the diagnosis of neurobrucellosis. Int J Infect Dis. 2018 Feb; 67:20-24.
    View in: PubMed
    Score: 0.007
  15. Seroepidemiology of enterovirus D68 infection in China. Emerg Microbes Infect. 2017 May 10; 6(5):e32.
    View in: PubMed
    Score: 0.006
  16. Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus. J Virol. 2007 May; 81(9):4694-700.
    View in: PubMed
    Score: 0.003
  17. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J Virol. 2004 Oct; 78(20):11334-9.
    View in: PubMed
    Score: 0.003
  18. [Severe acute respiratory syndrome: a singular epidemic of viral pneumonia]. Presse Med. 2004 Mar 13; 33(5):344-51.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.